Published in JAMA on November 15, 2006
Prognostic indices for older adults: a systematic review. JAMA (2012) 5.70
Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med (2013) 4.59
Trends in the overuse of ambulatory health care services in the United States. JAMA Intern Med (2013) 3.39
Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol (2010) 2.89
Comparative effectiveness and health care spending--implications for reform. N Engl J Med (2010) 2.81
Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med (2009) 2.24
The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care (2009) 2.10
Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result. Urology (2014) 2.09
Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare. J Am Geriatr Soc (2010) 2.08
Levels and variation in overuse of fecal occult blood testing in the Veterans Health Administration. J Gen Intern Med (2012) 2.06
Prostate-specific antigen testing among the elderly in community-based family medicine practices. J Am Board Fam Med (2009) 1.76
Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Aff (Millwood) (2013) 1.63
Prostate specific antigen testing among the elderly--when to stop? J Urol (2009) 1.62
Variation among primary care physicians in prostate-specific antigen screening of older men. JAMA (2013) 1.57
Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol (2012) 1.52
Biomarkers in prostate cancer surveillance and screening: past, present, and future. Ther Adv Urol (2013) 1.48
Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold. Urology (2014) 1.43
Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol (2012) 1.39
Expected population impacts of discontinued prostate-specific antigen screening. Cancer (2014) 1.24
An evaluation of the Veterans Health Administration's clinical reminders system: a national survey of generalists. J Gen Intern Med (2008) 1.23
Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration. J Gen Intern Med (2015) 1.19
Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support. J Gen Intern Med (2015) 1.17
PSA testing: public policy or private penchant? JAMA (2006) 1.14
Integrating age and comorbidity to assess screening mammography utilization. Am J Prev Med (2012) 1.05
Receipt of Cancer Screening Is a Predictor of Life Expectancy. J Gen Intern Med (2016) 1.04
Development of a 5 year life expectancy index in older adults using predictive mining of electronic health record data. J Am Med Inform Assoc (2013) 1.03
Provider recommendations for colorectal cancer screening in elderly veterans. J Gen Intern Med (2009) 1.00
What happens after an elevated PSA test: the experience of 13,591 veterans. J Gen Intern Med (2010) 0.99
Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners. BMC Fam Pract (2009) 0.99
Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. Arch Intern Med (2012) 0.99
Older adults and cancer treatment. Cancer (2008) 0.98
Use of electronic health record data to evaluate overuse of cervical cancer screening. J Am Med Inform Assoc (2012) 0.96
Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy. J Gen Intern Med (2011) 0.96
Potential overuse of screening mammography and its association with access to primary care. Med Care (2014) 0.96
The cost implications of prostate cancer screening in the Medicare population. Cancer (2013) 0.95
Participation of very old adults in health care decisions. Med Decis Making (2013) 0.95
Five-year downstream outcomes following prostate-specific antigen screening in older men. JAMA Intern Med (2013) 0.93
The impact of PSA testing frequency on prostate cancer incidence and treatment in older men. Prostate Cancer Prostatic Dis (2011) 0.93
Overuse and systems of care: a systematic review. Med Care (2013) 0.92
Durable improvements in prostate cancer screening from online spaced education a randomized controlled trial. Am J Prev Med (2010) 0.91
Prostate-specific antigen screening can be beneficial to younger and at-risk men. CMAJ (2012) 0.88
Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies. Clin Gastroenterol Hepatol (2013) 0.88
Influence of patient age and comorbid burden on clinician attitudes toward heart failure guidelines. Am J Geriatr Pharmacother (2012) 0.88
Race/Ethnicity and overuse of care: a systematic review. Milbank Q (2015) 0.87
The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample. Med Care (2012) 0.87
Sexual orientation and testing for prostate and colorectal cancers among men in California. Med Care (2008) 0.87
PSA and beyond: alternative prostate cancer biomarkers. Cell Oncol (Dordr) (2016) 0.86
The impact of technology diffusion on treatment for prostate cancer. Med Care (2013) 0.85
Prostate-specific antigen (PSA) screening: has the pendulum swung too far? Asian J Androl (2011) 0.82
Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System. Prev Chronic Dis (2010) 0.82
Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy. JAMA Intern Med (2016) 0.81
Semicompeting risks in aging research: methods, issues and needs. Lifetime Data Anal (2014) 0.81
Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening. BMC Cancer (2011) 0.79
Remaining Life Expectancy Measurement and PSA Screening of Older Men. J Geriatr Oncol (2012) 0.79
Evaluation and Management of the Geriatric Urologic Oncology Patient. Curr Geriatr Rep (2015) 0.78
Prostate cancer testing following a negative prostate biopsy: over testing the elderly. J Gen Intern Med (2007) 0.78
Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans? Urol Oncol (2013) 0.78
Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer. Front Oncol (2016) 0.78
"No Turning Bax" in the combined battle against prostate cancer:. Clin Cancer Res (2007) 0.77
Current trends in diagnostic and therapeutic principles for prostate cancer in Japan. Int J Clin Oncol (2008) 0.76
Depression screening as a quality indicator. Ment Health Fam Med (2010) 0.76
Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med (2016) 0.76
Lack of follow-up of prostate-specific antigen test results. Public Health Rep (2009) 0.76
Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells. Mol Cells (2015) 0.75
Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study. BMC Health Serv Res (2016) 0.75
Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DC. Rev Urol (2011) 0.75
Prostate cancer: Lessons from PIVOT lost in media hype. Nat Rev Urol (2012) 0.75
Obesity and the receipt of influenza and pneumococcal vaccination: a systematic review and meta-analysis. BMC Obes (2016) 0.75
PSA screening and elderly men. JAMA (2007) 0.75
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy. Cancers (Basel) (2017) 0.75
80 is the new 60: implications of irrational exuberance regarding longevity on prostate cancer treatment decisions. J Gen Intern Med (2012) 0.75
How common is PSA screening in elderly men with limited life expectancies? Nat Clin Pract Urol (2007) 0.75
Health services research is translational: lessons learned from VHA-funded research on cancer screening in older adults. Transl Behav Med (2011) 0.75
Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening. Cancer J (2017) 0.75
Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis. Onco Targets Ther (2017) 0.75
Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study. Health Expect (2016) 0.75
Socioeconomic Differences in Use of Low-Value Cancer Screenings and Distributional Effects in Medicare. Health Serv Res (2016) 0.75
Barriers and facilitators associated with colonoscopy completion in individuals with multiple chronic conditions: a qualitative study. Patient Prefer Adherence (2017) 0.75
Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14
Development and validation of a prognostic index for 4-year mortality in older adults. JAMA (2006) 6.79
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA (2002) 5.13
Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer (2008) 4.77
The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA (2004) 4.73
Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry (2010) 4.27
Bringing the war back home: mental health disorders among 103,788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities. Arch Intern Med (2007) 4.07
Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am J Public Health (2009) 3.95
Physiological studies of Escherichia coli strain MG1655: growth defects and apparent cross-regulation of gene expression. J Bacteriol (2003) 3.29
Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer (2008) 3.14
Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Ann Intern Med (2004) 2.92
Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol (2006) 2.78
Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol (2011) 2.68
Use of a modified informed consent process among vulnerable patients: a descriptive study. J Gen Intern Med (2006) 2.46
High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev (2002) 2.46
Functional limitations, socioeconomic status, and all-cause mortality in moderate alcohol drinkers. J Am Geriatr Soc (2009) 2.33
Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med (2004) 2.31
Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med (2009) 2.24
White/black racial differences in risk of end-stage renal disease and death. Am J Med (2009) 2.16
VA mental health services utilization in Iraq and Afghanistan veterans in the first year of receiving new mental health diagnoses. J Trauma Stress (2010) 2.09
Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord (2006) 2.01
Pain, functional limitations, and aging. J Am Geriatr Soc (2009) 1.88
Depressive symptoms in middle age and the development of later-life functional limitations: the long-term effect of depressive symptoms. J Am Geriatr Soc (2010) 1.88
Recurrence of high-risk bladder cancer: a population-based analysis. Cancer (2013) 1.87
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res (2006) 1.73
Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol (2007) 1.73
Quality of care in patients with bladder cancer: a case report? Cancer (2011) 1.73
Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med (2009) 1.70
Getting beyond "Don't ask; don't tell": an evaluation of US Veterans Administration postdeployment mental health screening of veterans returning from Iraq and Afghanistan. Am J Public Health (2008) 1.67
An advance directive redesigned to meet the literacy level of most adults: a randomized trial. Patient Educ Couns (2007) 1.63
Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis (2007) 1.62
Serum leptin level and cognition in the elderly: Findings from the Health ABC Study. Neurobiol Aging (2008) 1.59
Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura. Am J Hematol (2009) 1.58
Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol (2007) 1.57
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer (2011) 1.55
Engagement in multiple steps of the advance care planning process: a descriptive study of diverse older adults. J Am Geriatr Soc (2008) 1.52
Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic. Med Care (2004) 1.51
Cutaneous metastases from transitional cell carcinoma of the bladder. Urology (2006) 1.50
Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database. Urology (2005) 1.47
Mental health diagnoses and utilization of VA non-mental health medical services among returning Iraq and Afghanistan veterans. J Gen Intern Med (2009) 1.47
Telomere length and cognitive function in community-dwelling elders: findings from the Health ABC Study. Neurobiol Aging (2009) 1.46
Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology (2006) 1.46
Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med (2007) 1.45
Association of cardiovascular risk factors with mental health diagnoses in Iraq and Afghanistan war veterans using VA health care. JAMA (2009) 1.45
The relationship between self-rated health and mortality in older black and white Americans. J Am Geriatr Soc (2007) 1.45
Factors associated with reduction in use of neoadjuvant androgen suppression therapy before radical prostatectomy. Urology (2013) 1.44
Cavernous nerve repair with allogenic adipose matrix and autologous adipose-derived stem cells. Urology (2011) 1.43
Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costs. Urology (2005) 1.41
Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women. Urology (2011) 1.39
Development and validation of an index to predict activity of daily living dependence in community-dwelling elders. Med Care (2006) 1.35
The effect of maintaining cognition on risk of disability and death. J Am Geriatr Soc (2010) 1.35
Chronic conditions and mortality among the oldest old. Am J Public Health (2008) 1.34
Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol (2007) 1.29
Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002. J Urol (2007) 1.27
Total and regional adiposity and cognitive change in older adults: The Health, Aging and Body Composition (ABC) study. Arch Neurol (2009) 1.26
Cystatin C as a marker of cognitive function in elders: findings from the health ABC study. Ann Neurol (2008) 1.24
The impact of marriage on bladder cancer mortality. Urol Oncol (2008) 1.23
Black-white disparities in functional decline in older persons: the role of cognitive function. J Gerontol A Biol Sci Med Sci (2005) 1.18
Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg (2009) 1.17
New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol (2006) 1.14
The impact of provider volume on outcomes from urological cancer therapy. J Urol (2005) 1.11
Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg (2011) 1.10
Conflicts and concordance between measures of medication prescribing quality. Med Care (2007) 1.10
Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int (2011) 1.10
Quality of life in long-term survivors of bladder cancer. Cancer (2006) 1.09
Does the interval between prostate biopsy and radical prostatectomy affect the immediate postoperative outcome? BJU Int (2006) 1.09
Prostate cancer screening parameters in a high-risk African-Caribbean population. Urology (2004) 1.08
Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief? BJU Int (2009) 1.07
Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. J Urol (2007) 1.06
Retracted Functional characterization of the bladder cancer marker, BLCA-4. Clin Cancer Res (2004) 1.06
Being old and doing time: functional impairment and adverse experiences of geriatric female prisoners. J Am Geriatr Soc (2006) 1.05
Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol (2004) 1.05
Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture. Cancer (2011) 1.04
Childhood social and economic well-being and health in older age. Am J Epidemiol (2007) 1.04
The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy. J Urol (2006) 1.03
Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results. Clin Cancer Res (2009) 1.01
Use of bipolar power source for transurethral resection of bladder tumor in patient with implanted pacemaker. Urology (2005) 1.01
Medication prescribing practices for older prisoners in the Texas prison system. Am J Public Health (2009) 1.00
The prevalence of renal cell carcinoma diagnosed at autopsy. BJU Int (2005) 1.00
The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int (2008) 1.00
Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study. Neurobiol Aging (2007) 1.00
Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer (2004) 0.99
Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review. Am J Hematol (2009) 0.99
Reproductive and other health outcomes in Iraq and Afghanistan women veterans using VA health care: association with mental health diagnoses. Womens Health Issues (2012) 0.99
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update. BJU Int (2015) 0.97
Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression. Nat Clin Pract Urol (2008) 0.96
Candidate quality of care indicators for localized bladder cancer. Urol Oncol (2009) 0.96
Reducing barriers to mental health and social services for Iraq and Afghanistan veterans: outcomes of an integrated primary care clinic. J Gen Intern Med (2011) 0.95
Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer. Urol Oncol (2009) 0.94
Effect of meeting Leapfrog volume thresholds on complication rates following complex surgical procedures. Ann Surg (2010) 0.94
Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treat (2005) 0.93
Caregiving behind bars: correctional officer reports of disability in geriatric prisoners. J Am Geriatr Soc (2009) 0.93
The example of CaPSURE: lessons learned from a national disease registry. World J Urol (2011) 0.92
The relationship between body mass index and mental health among Iraq and Afghanistan veterans. J Gen Intern Med (2013) 0.92
Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis. Urology (2003) 0.91
The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor. Genes Cancer (2013) 0.91